Navigation Links
NCPA Digest Finds Independent Community Pharmacies Reducing Health Costs Through Generic Drug Use, Patient Counseling
Date:10/10/2011

NASHVILLE, Tenn., Oct. 10, 2011 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association (NCPA) today announced the availability of the 2011 NCPA Digest, sponsored by Cardinal Health, a comprehensive survey of the current state of independent community pharmacies. It finds that independent community pharmacies continue evolving to meet patient health needs, reduce costs, and remain a viable small business model amid a tough economic landscape, declining prescription drug reimbursements by public and private health plans, and rising expenses, such as employee salaries.

(Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO)

"The 2011 NCPA Digest, sponsored by Cardinal Health, offers further proof of the adaptability and innovation of independent community pharmacists as they try to overcome significant challenges to keep serving patients," said B. Douglas Hoey, RPh, MBA, NCPA executive vice president and CEO. "By offering a variety of patient-friendly niches to complement the prescription drugs they dispense, independent community pharmacies continue to distinguish themselves from their competitors and win kudos from patients."

"Community pharmacists continue to play a vital role in improving health outcomes while reducing costs," Hoey added. "First, the Digest indicates that community pharmacists reached new highs in promoting the appropriate use of lower-cost generic drugs. Second, they are providing critical, face-to-face patient counseling on the proper use of medications, and on combating diabetes and other common conditions. These clinically trained, small business health care providers stand ready to reduce costs further, such as through coordinated care models, so long as the unsustainable rate of reimbursement cuts ceases."  

Now in its 79th year, the NCPA Digest provides these noteworthy 2010 findings:

  • Fueled by declining reimbursement rates and rising business costs, the number of total independent community pharmacies decreased slightly from 23,117 to 23,064.
  • The average independent community pharmacy's pretax net profit margin fell from 3.2 percent to 3.0 percent,
  • Approximately 92 percent of revenue is derived from the sale of prescription drugs.
  • Continuing to fill the void in underserved areas, the number of independent community pharmacies in areas of 20,000 people or less, remained constant at 52 percent.
  • There was a small decline in the average amount of prescription drugs dispensed from 64,635 to 64,169, although the number of refills increased slightly.
  • Independent community pharmacies set a new high in generic drug utilization, increasing their "generic dispensing rate" from 69 percent to 72 percent.
  • The number of prescription drugs dispensed under the Medicare Part D program remains at 30 percent. In a sign of the tough economy, the number of Medicaid prescription drugs dispensed rose from 14 percent to 16 percent.
  • Home delivery (76 percent of pharmacies offer it free of charge) and compounding (66 percent) remained among the most common niche services offered by independent community pharmacies.
  • Disease state management services (immunization, blood pressure monitoring, diabetes training, etc.) or medication therapy management (MTM) service were offered by 78 percent of pharmacies.
  • In terms of cutting-edge advancements, 90 percent of independents are connected for e-prescribing and 72 percent use point-of-sale technology.

"Cardinal Health is proud to sponsor the NCPA Digest, which provides vital demographic, business, and financial information about independent community pharmacies," said Jay Williams, vice president of marketing management for Cardinal Health's Retail Pharmacy business. "This important industry resource helps NCPA identify how they can better assist members in providing quality, personalized care to patients and helps pharmacy owners improve their businesses by benchmarking their performance against their peers."

In light of the Digest findings, NCPA reiterated its support for policies to support the patient's choice of pharmacy and to promote pharmacy competition:

  • Rejecting the proposed merger of two of the three largest pharmacy benefit managers (PBMs) Express Scripts and Medco – opposed by consumer groups, questioned by members of Congress, and currently under Federal Trade Commission review;
  • U.S. Senate and House bills the Pharmacy Competition and Consumer Choice Act of 2011(S. 1058 / H.R. 1971), which seek to promote patient choice and address unreasonable pharmacy audits; and
  • The Preserving Our Hometown Independent Pharmacies Act (H.R. 1946) to allow independent community pharmacies to collectively bargain for fairer contracts with PBMs, which administer many prescription drug plans and also operate competing mail order pharmacies.

"When 89 percent of prescriptions are covered by third party contracts, which are dominated by PBMs, there should be a focus on achieving a fairer and more competitive pharmacy marketplace," said Robert J. Greenwood, RPh, NCPA president and pharmacy owner in Waterloo, Iowa. "That is why we continue to press our case at every opportunity for these pro-patient, pro-pharmacist policies. We will also continue to work with policymakers and stakeholders on forward-looking issues such as the development of accountable care organizations and state health insurance exchanges."

The National Community Pharmacists Association (NCPA®) represents the interests of America's community pharmacists, including the owners of more than 23,000 independent community pharmacies. Together they represent a $93 billion health care marketplace, dispense over 37% of all retail prescriptions, and employ more than 315,000 people, including 62,400 pharmacists.  Independent community pharmacists are readily accessible medication experts who can help lower health care spending. They are committed to maximizing the appropriate use of lower-cost generic drugs and reducing the estimated $290 billion that is wasted annually by improper medication use. To learn more go to www.ncpanet.org or read NCPA's blog, The Dose, at http://ncpanet.wordpress.com.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Male Birth Control Pill, Blackberry Extract for Gingivitis, Skin Cancer and Digestive Health Top List of New Medical Discoveries
2. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
3. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
4. Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities
5. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
6. Definitive Outcomes of Radiofrequency Ablation for Barretts Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting for Gastroenterologists and Esophageal Surgeons
7. Weekly Digests Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 Swine Flu Outbreak
8. CREON(R) (pancrelipase) Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis
9. Kristalose(R) Clinical Data to Be Presented at Digestive Disease Week(R) Meeting
10. Lexicon to Present Phase 2 Clinical Data for IBS Drug Candidate at Digestive Disease Week
11. ChemoCentryx Reports that Traficet-EN Maintains Remission in Crohns Disease at the Digestive Disease Week (DDW) 2010 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... , July 12, 2017 CarpalAID is a revolutionary new ... or surgery. Carpal tunnel syndrome affects more than 8 ... twice the rate of men. The common methods of treating CTS ... with uncomfortable hand braces or gloves. ... CarpalAID is a clear patch worn ...
(Date:7/11/2017)... Corp., also known as ,The Epigenetics Company, announced today the release of ... using the myDNAge ™ test. Based on Horvath,s Clock, so named ... biostatistics at the David Geffen School of Medicine at UCLA ... ™ technology is used to analyze DNA methylation patterns of over ... Epigenetic ...
(Date:7/11/2017)... ROCKVILLE, Md. , July 11, 2017  The ... had estimated revenues of approximately $394.1 million in 2016.  ... a trend of solid growth, in particular as a ... oncology clinical practice, and the recent introduction of a ... the need for less-invasive testing of tumor biomarkers to ...
Breaking Medicine Technology:
(Date:7/28/2017)... ... 2017 , ... For over 20 years Sealy Baby has been creating crib ... take tremendous pride in using some of nature’s best materials while integrating today’s latest ... crib mattresses and crib bedding for infants and toddlers. We ...
(Date:7/28/2017)... Arizona (PRWEB) , ... July 28, 2017 , ... ... Arizona’s Premier Center for Shamanic Healing and Spiritual Awakening, is proud to ... October 21–23, 2017. , Those interested in learning more about the mystical ...
(Date:7/27/2017)... ... July 27, 2017 , ... Trusted dentist, speaker and community ... apnea in Wayne, NJ to receive custom treatment at his practice with ... with the use of custom-crafted oral appliances. Highly-trained in using the latest sleep ...
(Date:7/27/2017)... ... ... TransPanel Volume 4 is a collection of animating panel transitions made for ... that contain between 2 and 6 animated panels. Change the direction of panels vertically ... 4 makes editing easy in Final Cut Pro X. , TransPanel Volume 4 is ...
(Date:7/27/2017)... ... July 27, 2017 , ... SSCI, a division of ... patent challenges worldwide, representing a milestone achievement. , As an industry-leading ... SSCI scientists have served as expert and fact witnesses to assist our clients ...
Breaking Medicine News(10 mins):